• Skip to content
  • Skip to primary sidebar

Fross Zelnick Lehrman & Zissu, P.C.®

  • People
  • Focus
  • Services

    Find Your Lawyer

    Alejandra Camacho LunaJohn P. MargiottaParker C. EudyLauren NathanRobert A. BeckerKatherine Lyon DaytonCharles T.J. Weigell, IIICourtney B. ShierNancy E. SabarraJason D. JonesMaritza C. SchaefferJessica G. OgdenLydia T. GobenaNancy DiConzaDavid A. DonahueAshford TuckerAlexandra E. KochianRobin N. BaydurcanJames D. SilbersteinJames D. WeinbergerNadine H. JacobsonCarlos CucurellaJoyce M. FerraroMassimo B. CapizziShelby P. RokitoNicole TenoreAllison Strickland RickettsCole S. MathewsLeo KittaySherri N. DuitzLaura Popp-RosenbergBrian LearyBarbara A. SolomonRichard Z. LehvEric T. GordonJ. Asheton LemayCarole E. KlingerAmanda B. AgatiEsteban Monge-MoreraCraig S. MendeAndrew N. FredbeckDarra FrinoAdrian E. Harrison Jr.Mary StotteleChristina SauerbornAngela RamanauskasSarah MarmonJanet L. HoffmanTamar Niv BessingerTodd Martin
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • u
    • v
    • w
    • x
    • y
    • z
    • View All
ShareBookmarkPrint

June 16, 2023

Genzyme Corporation v. Hilali Noordeen

The Trademark Trial and Appeal Board issued the decision after trial sustaining Fross Zelnick’s oppositions to REGENAL and REGENALL (for “pharmaceutical preparations for the treatment of damaged or injured tissue; nutritional supplements”) based on our client Genzyme Corporation’s mark, RENAGEL, registered for “pharmaceuticals, namely, phosphate binders for treatment of hyperphosphatemia.” Hyperphosphatemia is an electrolyte disorder, which results in elevated levels of phosphate in the patient’s blood, usually patients with chronic kidney disease.

View Related Document (file: Genzyme Corporation v. Hilali Noordeen)

Primary Sidebar

Related

People

  • Richard Z. Lehv

    Senior Litigation Counsel

Focus

  • Pharmaceuticals

Services

  • Trademark
  • Litigation
  • Sitemap
© 2025 Fross Zelnick Lehrman & Zissu, P.C.®
  • Fross Zelnick and FZ are registered trademarks of Fross Zelnick Lehrman & Zissu, P.C.
  • Attorney Advertising
  • Legal & Privacy
  • Connect with us on LinkedIn
  • Contact

Stay Connected

  • People
  • Focus
    • Celebrities, Bands & Athletes
    • Consumer Products
    • Entertainment Properties
    • Fashion
    • Startup & Emerging Growth
    • Food & Beverage
    • Hospitality & Hotels
    • Jewelry & Watches
    • Non-Fungible Tokens (NFTs)
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Professional Services
    • Publishing
    • Sports
    • Toys
  • Services
    • Trademark
    • Copyright
    • Design
    • Data Privacy
    • Publicity & Privacy Rights
    • Litigation
    • International
    • Transactions
    • Social Media & Domain Names
  • Decisions
  • Newsroom
  • Our Firm
    • About Our Firm
    • Diversity & Inclusion
    • Recognition
    • Careers
    • Pro Bono
    • Contact